ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1540 | Terminated | Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) | Covid19 | Biological: ConvP Biological: FFP |
Phase 3 | Erasmus Medical Center, Prothya Biosolutions, ZonMw: The Netherlands Organisation for Health Research and Development, Leiden University Medical Center | OTHER | 420 | All | 50 Years | Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands Meander Medisch Centrum, Amersfoort, Netherlands Rijnstate Ziekenhuis, Arnhem, Netherlands Amphia Ziekenhuis, Breda, Netherlands Groene Hart Ziekenhuis, Gouda, Netherlands University Medical Center Groningen (UMCG), Groningen, Netherlands Spaarne Gasthuis, Haarlem, Netherlands Medisch Centrum Leeuwarden, Leeuwarden, Netherlands Leids Universitair Medisch Centrum, Leiden, Netherlands Sint Antonius Ziekenhuis, Nieuwegein, Netherlands Bernhoven Hospital, Uden, Netherlands |
1539 | Recruiting | Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19 | COVID-19 | Biological: Current standard of care and COVID-19 convalescent and vaccinated plasma Other: Current standard of care |
Phase 3 | Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen, NHS Blood and Transplant | OTHER | 680 | All | CHU Besancon, Besancon, France Stauferklinikum Schwabisch Gmund, Mutlangen, Baden-Wuerttemberg, Germany Klinikum Stuttgart, Stuttgart, Baden-Wuerttemberg, Germany Diakonie-Klinikum Stuttgart, Stuttgart, Baden-Wuerttemberg, Germany Uniklinikum Tubingen, Tubingen, Baden-Wuerttemberg, Germany Institut fur Klinische Transfusionsmedizin (IKT), Ulm, Baden-Wuerttemberg, Germany Uniklinikum Ulm, Ulm, Baden-Wuerttemberg, Germany Universitatsklinikum Brandenburg, Brandenburg an der Havel, Brandenburg, Germany Universitatsklinikum Frankfurt, Frankfurt, Hessen, Germany Elblandkliniken Riesa, Riesa, Sachsen, Germany Charite Medizinische Klinik IV, Berlin, Germany Klinikum Chemnitz gGmbH, Chemnitz, Germany Erasmus Medical Center, Rotterdam, Netherlands NHS Blood and Transplant, Oxford, United Kingdom |
|
1538 | Completed | Early Intervention in COVID-19: Favipiravir Verses Standard Care | Coronavirus Infection | Drug: Favipiravir Other: Standard of care management |
Phase 3 | Chelsea and Westminster NHS Foundation Trust, NEAT ID Foundation, FUJIFILM Toyama Chemical Co., Ltd., Imperial College London | OTHER | 502 | All | 18 Years | Grupo Hospitalar Conceicao, Porto Alegre, Brazil Fundacao Oswaldo Cruz - Instituto Nacional de Infectologia Evandro Chagas (Fiocruz/INI), Rio De Janeiro, Brazil Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City, Mexico Hull University Teaching Hospitals NHS Trust - Castle Hill Hospital, Hull, United Kingdom Chelsea and Westminster Hospital, London, United Kingdom West Middlesex University Hospital, London, United Kingdom |
1537 | Terminated | Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients | COVID-19 | Drug: Enoxaparin | Phase 3 | Thrombosis Research Institute, Sanofi | OTHER | 219 | All | 55 Years | Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital, Melbourne, Australia Dr Frank Cools, National Co-ordinating Investigator, AZ Klina, Brasschaat, Belgium Prof. Barry Jacobson, National Coordinating Investigator, University of the Witwatersrand, Johannesburg, South Africa |
1536 | Completed | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. | Coronavirus Disease 2019 )COVID-19) | Biological: COVID-19 Convalescent Plasma | Phase 3 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | OTHER | 29 | All | 65 Years | Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy Ospedale SS Annunziata, Chieti, Italy Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy |
1535 | Completed | Early Treatment of Cytokine Storm Syndrome in Covid-19 | COVID-19 | Drug: Anakinra Drug: Normal saline |
Phase 3 | University of Alabama at Birmingham | OTHER | 32 | All | 18 Years ~ 80 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States |
1534 | Unknown status | Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2 | Dexamethasone | Drug: Dexamethasone | Phase 3 | Hospital Universitario Infanta Leonor | OTHER | 200 | All | 18 Years |